Literature DB >> 8572192

Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation.

S L Perkins1, S J Kling.   

Abstract

Macrophage colony-stimulating factor (M-CSF) is essential for differentiation of osteoclasts and macrophages from a common bone marrow precursor. Using ST-2 stromal cell/murine bone marrow coculture, we studied the effects of increasing amounts of M-CSF on differentiation of macrophages and osteoclasts. Addition of exogenous M-CSF caused a dose-dependent 98% decrease in tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells, accompanied by a 2.5-fold increase in nonspecific esterase-staining macrophages. Similar decrease in osteoclastic functional activity, including 125I-labeled calcitonin binding and calcitonin-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) production, were observed. Addition of exogenous M-CSF beyond 6 days in coculture had a decreasing ability to inhibit osteoclast formation, suggesting that M-CSF exerts its effects early in osteoclast differentiation, during the proposed proliferative phase of osteoclast formation. Similarly, early addition of neutralizing anti-M-CSF inhibited osteoclast formation, with diminishing effects beyond day 9. These results suggest that local high concentrations of M-CSF may influence the early determination of terminal differentiation into either macrophages or osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572192     DOI: 10.1152/ajpendo.1995.269.6.E1024

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

2.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction.

Authors:  Shane A Lloyd; Yuyu Y Yuan; Steven J Simske; Stephanie E Riffle; Virginia L Ferguson; Ted A Bateman
Journal:  J Bone Miner Metab       Date:  2009-03-27       Impact factor: 2.626

4.  PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts.

Authors:  Violeta Chitu; Viorel Nacu; Julia F Charles; William M Henne; Harvey T McMahon; Sayan Nandi; Halley Ketchum; Renee Harris; Mary C Nakamura; E Richard Stanley
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113

5.  Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-{kappa}B ligand (RANKL) expression by osteoblasts.

Authors:  Y Wittrant; Y Gorin; S Mohan; B Wagner; S L Abboud-Werner
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

6.  Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).

Authors:  Wataru Ando; Jun Hashimoto; Akihide Nampei; Hideki Tsuboi; Kosuke Tateishi; Takeshi Ono; Norimasa Nakamura; Takahiro Ochi; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.976

7.  Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation.

Authors:  G Mbalaviele; R Nishimura; A Myoi; M Niewolna; S V Reddy; D Chen; J Feng; D Roodman; G R Mundy; T Yoneda
Journal:  J Cell Biol       Date:  1998-06-15       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.